Using genetic and pharmacological approaches, our study now demonstrates that 25‐HC, the enzymatic product of CH25H, provides renoprotection in diabetic kidneys by binding to and enhancing the activation of ADP ribosylation factor‐4 (ARF4). The gene discussed is ARF4; the disease is diabetes mellitus.